Why Rare Cannabinoids Are In Demand with WTR's Jesse Redmond and BayMedica's Jerry Griffin

Send us a text

BayMedica is the commercial business arm of rare cannabinoids-based drug developer InMed Pharmaceuticals (NASDAQ: INM). BayMedica produces and sells synthesized high purity and consistent rare cannabinoid ingredients to the Health & Wellness sector. BayMedica’s business has quickly grown its annual revenues to more than $5 million over the last 12 months.